Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.40 |
| ▸ | CCR10 | P46092 | 2/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.38 |
| ▸ | ITGAV | P06756 | 8/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.38 |
| ▸ | PNMT | P11086 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | PLG | P00747 | 1/20 | 0.37 |
| ▸ | PLAU | P00749 | 1/20 | 0.37 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9055891 | 0.98 | F2 (0.40) | F2CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9055156 | 0.96 | F2 (0.41) | F2CCR10ITGB3ITGAVITGA2B | |
| SCHEMBL9055359 | 0.86 | CCR10 (0.46) | F2CCR10F10 | |
| SCHEMBL9057049 | 0.85 | F2 (0.39) | F2ITGB3ITGAVITGA2BF10 | |
| SCHEMBL9057054 | 0.84 | ITGB3 (0.39) | F2ITGB3ITGAVITGA2B | |
| SCHEMBL9055170 | 0.82 | F2 (0.38) | F2ITGB3ITGAVITGA2B | |
| SCHEMBL9057042 | 0.82 | F2 (0.43) | F2ITGB3ITGAVITGA2B | |
| SCHEMBL9056476 | 0.81 | F2 (0.39) | F2ITGB3ITGAVITGA2B | |
| SCHEMBL9058407 | 0.81 | F2 (0.42) | F2ITGB3ITGAVITGA2BF10 | |
| SCHEMBL9057565 | 0.80 | F2 (0.42) | F2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996002517-A1 | SUBSTITUTED ARYLSULFONAMIDES, THEIR PREPARATION AND USE AS THROMBIN-INHIBITING MEDICAMENTS | DR. KARL THOMAE GMBH (DE) | 1996-02-01 | — | — | WO | disclosed |